Blue Cross Blue Shield to Require at-Home Injections for Some Asthma Medications
Blue Cross Blue Shield (BCBS), under its parent company Health Care Service Corporation, is changing how certain asthma injections are administered.
Effective April 15, 2025, some patients will need to self-administer asthma medications at home rather than receiving them at a clinic. The affected medications include Fasenra, Tezspire, Nucala, and Xolair.
BCBS will update coverage... Read More.
